Speaking Engagements (Staff, Collaborators, Strategic Partners)

May 10-11, 2017
Palo Alto, CA
Leaders In Global Healthcare & Technology (LIGHT) (Gigi Hirsch) Panel TBA (John Glasspool, Moderator)
January 23, 2017
Washington, DC
DIA Integrated Adaptive Development and Decision Making Conference (Gigi Hirsch) Panel: Adaptive Biomedical Innovations: The Way Forward (Stella Blackburn, Moderator)

2016 Speaking Engagements

December 12, 2016
Washington, DC
The Drug Development Paradigm in Oncology hosted by the National Cancer Policy Forum. (G.K. Raju)
October 5
La Jolla, CA
2016 Cell & Gene Meeting on the Mesa. “The Impact of a New Healthcare Model: What Do Payers Think of Gene Therapies?” (Mark Trusheim)
September 21
New York, NY
NBER Pre-Conference on Economic Dimensions of Personalized and Precision Medicine. “The Competitive Dynamics of Personalized and Precision Medicine: Insights from Game Theory” (Mark Trusheim)
June 26-30 Philadelphia, PA DIA 52nd Annual Meeting (Gigi Hirsch & Hans-Georg Eichler – Session Co-Chairs).
June 29
Philadelphia, PA
DIA 52nd Annual Meeting. “Europe and the US: Making Outcomes-Based Health Care Possible.” Details here. (Gigi Hirsch).
June 8
San Francisco
BIO 2016. “Curative Therapies: Aligning Policy with Science to Ensure Patient Access” (Mark Trusheim).
April 21-22
Duke University, Durham
Presentation to Kenan Institute Symposium on US-EU Regulatory Cooperation. “Adaptive Pathways and Biomedical Innovation in the EU, US and Japan” (Ken Oye).
April 21-22 Amsterdam Belgian Healthcare Knowledge Center (HKC) & WHO jointly sponsored Drug Pricing Scenarios Project – Part 2 (Mark Trusheim).
April 21-22 Washington, DC Annual World Orphan Drug Congress. “Adaptive Biomedical Innovation: Re-engineering How We Innovate” (Gigi Hirsch).
April 14
Basel, Switzerland
Roche educational presentation on MAPPS (Mark Trusheim).
March 21-22
San Francisco
Future of Health Program, co-sponsored by Silicon Valley Executive Network (SVEN), Decision Resources Group, and MIT Media Lab. “Adaptive Biomedical Innovation: Transforming Big Data Hype into Patient Value” (Tom Unger).
March 17-18 Amsterdam Belgian Healthcare Knowledge Center (HKC) & WHO jointly sponsored Drug Pricing Scenarios Project (Report to be presented to Dutch EU Presidency in June 2016) – Part 1 (Mark Trusheim).
January 27-29
Washington, DC
DIA’s Annual Pharmacovigilance and Risk Management Strategies conference – Panel Debate on “Earlier Access vs. Safety?” (Hans-Georg Eichler & Ken Oye).